Home > Insider Trading > Filing (0001209191-18-038597)

Filing Details

Accession Number:: 0001209191-18-038597
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-06-19 16:48:23
Reporting Period:: 2018-06-15

Accepted Time:: 2018-06-19 16:48:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
742112	Invacare Corp	IVC	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	952680965

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1520926	R. Baiju Shah	One Invacare Way Elyria OH 44035		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2018-06-15	4,000	$19.65	42,941	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Shares	Stock Option (Right to Buy)	$0.00			4,496	4,496	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	4,496	4,496	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Includes 15,314 previously reported restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan. 8,606 of these restricted stock units vested in full on May 15, 2018; however, the reporting person has elected to defer receipt of the common shares issuable upon the vesting of these restricted stock units until the earlier of January 1, 2027 or his separation from the issuer, pursuant to the Invacare Corporation 2012 Non-Employee Directors Deferred Compensation Plan. 6,708 of these restricted stock units vest in full on May 15, 2019; however, the reporting person has elected to defer receipt of the common shares issuable upon vesting of these restricted stock units until the earlier of January 1, 2027 or his separation from the issuer, pursuant to the 2012 Invacare Corporation Non-Employee Directors Deferred Compensation Plan.
No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
The reporting person holds previously reported options to buy 4,496 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted on May 19, 2011, at an exercise price of $33.36 per share, will expire on May 19, 2021, and became exercisable between March 31, 2012 and March 31, 2015.